Package 0069-1029-02

Brand: xeljanz

Generic: tofacitinib
NDC Package

Package Facts

Identity

Package NDC 0069-1029-02
Digits Only 0069102902
Product NDC 0069-1029
Product ID 0069-1029_60d5a945-0cec-4730-854b-d675fc116621
Description

1 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01)

Marketing

Marketing Status
Marketed Since 2021-02-08
Brand xeljanz
Generic tofacitinib
Sample Package No

Linked Drug Pages (1)

XELJANZ XR, XELJANZ ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "60d5a945-0cec-4730-854b-d675fc116621", "openfda": {"upc": ["0300691002018", "0300691001011"], "unii": ["O1FF4DIV0D"], "rxcui": ["1357541", "1357547", "1741046", "1741049", "2048566", "2048568", "2273113", "2273115", "2478433", "2478437"], "spl_set_id": ["cf74ba2f-afc5-4baa-8594-979c889a5831"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0069-1029-02)  / 240 mL in 1 BOTTLE (0069-1029-01)", "package_ndc": "0069-1029-02", "marketing_start_date": "20210208"}], "brand_name": "XELJANZ", "product_id": "0069-1029_60d5a945-0cec-4730-854b-d675fc116621", "dosage_form": "SOLUTION", "pharm_class": ["Janus Kinase Inhibitor [EPC]", "Janus Kinase Inhibitors [MoA]"], "product_ndc": "0069-1029", "generic_name": "tofacitinib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XELJANZ", "active_ingredients": [{"name": "TOFACITINIB CITRATE", "strength": "1 mg/mL"}], "application_number": "NDA213082", "marketing_category": "NDA", "marketing_start_date": "20210208", "listing_expiration_date": "20271231"}